Deepak Cyril D'Souza Selected Research

GABA Receptors (GABA Receptor)

2/2011

Probing GABA receptor function in schizophrenia with iomazenil.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deepak Cyril D'Souza Research Topics

Disease

25	Schizophrenia (Dementia Praecox) 01/2023 - 08/2004
24	Psychotic Disorders (Schizoaffective Disorder) 06/2023 - 08/2004
7	Neurobehavioral Manifestations 04/2016 - 04/2009
4	Cognitive Dysfunction 01/2023 - 07/2008
4	Substance-Related Disorders (Drug Abuse) 12/2020 - 08/2006
3	Major Depressive Disorder (Major Depressive Disorders) 01/2024 - 01/2022
2	Hallucinations (Hallucination) 12/2020 - 01/2020
2	Disease Susceptibility (Diathesis) 01/2016 - 06/2014
2	Alcoholism (Alcohol Abuse) 06/2014 - 08/2006
1	Treatment-Resistant Depressive Disorder 01/2022
1	Mental Disorders (Mental Disorder) 01/2020
1	Psychomotor Disorders 01/2020
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016
1	Multiple Sclerosis 01/2016
1	Vomiting 01/2016
1	Cachexia 01/2016
1	Neuralgia (Stump Neuralgia) 01/2016
1	Nausea 01/2016
1	Marijuana Use 01/2016
1	Tachycardia (Tachyarrhythmias) 09/2008
1	Psychomotor Agitation (Akathisia) 03/2005
1	Dyskinesias (Dyskinesia) 03/2005

Drug/Important Bio-Agent (IBA)

21	CannabinoidsIBA 06/2023 - 08/2004
7	Dronabinol (THC)FDA LinkGeneric 12/2020 - 03/2005
6	Ketamine FDA LinkGeneric 01/2022 - 08/2006
6	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016 - 08/2004
4	EndocannabinoidsIBA 12/2022 - 01/2016
4	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 03/2005
4	Nicotine FDA Link 01/2018 - 11/2012
3	N-Methylaspartate (NMDA)IBA 01/2023 - 08/2006
3	gamma-Aminobutyric Acid (GABA)IBA 11/2015 - 01/2006
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2014 - 03/2012
3	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2008 - 08/2004
2	Psilocybin (Psilocibin)IBA 01/2024 - 01/2023
2	1-methyl-1H-imidazole-4-carboxylic acid (3- chloro- 4- fluoro- benzyl)- (3- methyl- 3- aza- bicyclo(3.1.0) hex-6-ylmethyl)amideIBA 01/2023 - 01/2018
2	Glutamate Receptors (Glutamate Receptor)IBA 01/2023 - 08/2006
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2018 - 03/2012
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2012 - 03/2012
1	Glycine Plasma Membrane Transport ProteinsIBA 01/2023
1	N,N-Dimethyltryptamine (Dimethyltryptamine)IBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2020
1	serotonin 6 receptorIBA 01/2020
1	GSK215083IBA 01/2020
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	N-nitrosoiminodiacetic acidIBA 01/2019
1	N- pyridazin- 3- yl- 4- (3- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)benzylidene)piperidine- 1- carboxamideIBA 01/2019
1	SmokeIBA 01/2018
1	Cannabinoid Receptor AgonistsIBA 04/2016
1	Opioid Analgesics (Opioids)IBA 01/2016
1	Dopamine (Intropin)FDA LinkGeneric 11/2015
1	Amphetamine (Amfetamine)FDA LinkGeneric 11/2015
1	N- methyl- N- (6- methoxy- 1- phenyl- 1,2,3,4- tetrahydronaphthalen- 2- ylmethyl)aminomethylcarboxylic acidIBA 03/2012
1	Serine (L-Serine)FDA Link 03/2012
1	AcidsIBA 03/2012
1	Glutamic Acid (Glutamate)FDA Link 03/2012
1	GABA-A Receptors (GABA(A) Receptor)IBA 02/2011
1	GABA Receptors (GABA Receptor)IBA 02/2011
1	Butyric Acid (Butanoic Acid)IBA 02/2011
1	iomazenilIBA 02/2011
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2007
1	Naltrexone (ReVia)FDA LinkGeneric 08/2006
1	Opiate AlkaloidsIBA 08/2006
1	Serotonin (5 Hydroxytryptamine)IBA 01/2006
1	ProlactinIBA 03/2005

Therapy/Procedure

3	Therapeutics 01/2024 - 01/2021
2	Self Medication 01/2018 - 04/2016
2	Drug Therapy (Chemotherapy) 01/2016 - 08/2006
1	Cognitive Training 01/2023